http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2453297-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6379feda6e2eb9af0653088fc5870448 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
| filingDate | 2010-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f42f679c525fb6883bdcca02024ebf1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25d40d65506bc5ca4a9d98215f080272 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c01dcb45e995f737a54518920ea16dc6 |
| publicationDate | 2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2453297-C2 |
| titleOfInvention | Method for surgical management of macular oedema following cataract phacoemulsification |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely ophthalmosurgery, and may be used during surgical management of macular oedema following cataract phacoemulsification. It involves creating vitreomacular tractions by removing a posterior hyaloids of a vitreous body and an retinal internal limiting membrane is delayed after cataract phacoemulsification. n EFFECT: method allows eliminating retinal macular oedema, decreasing a retinal thickness and thereby providing higher visual acuity. n 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2668707-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2687592-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2659144-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2724009-C1 |
| priorityDate | 2010-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.